UK-US Pharma Deal Lacks Legal Text, MPs Warn
MPs warn UK's 'milestone' zero-tariff drug deal with the US is 'built on sand' with no legal text. Concerns grow as a separate £31bn tech deal is paused. Could the NHS pay more for nothing?
Category : Search result: pharmaceutical investment
EIB bosses stay cautious on hiring despite 2026 boom
Top executives at the European Investment Bank signal a continued hiring freeze for 2025, even as a major dealmaking surge is predicted for 2026. Explore the strategic reasons behind the caution.
UK-US Trade Deals: Medicines Pact & Tech Sovereignty Row
New UK-US medicines agreement aims to boost NHS access to innovative drugs, but critics warn of eroded sovereignty in wider trade pacts with Trump. Explore the debate.
AU$33m Pharma Payments to Doctors Raise Ethics Concerns
New data reveals over 6,500 Australian doctors received payments from drug firms. Experts warn this influences prescriptions, raising serious healthcare ethics questions. Read the full investigation.
Premium Whisky: The Perfect Gift and Investment Guide
Discover why premium whisky is the standout gift of 2025. From Hackstons' Knightsbridge store to rare cask investments, our guide covers how to give a legacy. Explore now.
UK-US Pharma Deal: NHS to Pay 25% More for New Drugs
A new UK-US deal doubling spending on US medicines raises NHS funding fears. Experts warn of a 'problematic precedent' that could impact Australia and global healthcare systems.
UK-US agree zero tariff deal on pharmaceuticals
The UK has secured a major three-year deal for zero US import tariffs on pharmaceuticals, safeguarding £5bn in annual exports and boosting life sciences investment. Read the full analysis.
UK-US zero-tariff pharma deal, NHS drug price rise
The UK and US have agreed a landmark deal maintaining zero tariffs on pharmaceuticals, while the NHS commits to a 25% net price increase for new medicines. Explore the details and implications.
US and UK agree zero-tariffs on pharmaceuticals
The US has agreed to spare the UK from threatened trade tariffs on pharmaceutical products, ensuring access to latest medical breakthroughs. Read the full details.
Clean energy investment hits lowest level in almost a decade
Investors warn of 'deep structural issues' causing a slump in solar and wind farm investment, threatening Australia's 2030 renewable energy targets. Read the full analysis.
FDA Implements Stricter Vaccine Approval Protocols
US regulator FDA announces major overhaul of vaccine approval process following COVID-19 review. New protocols aim to strengthen public trust in immunisation programmes.
Novo Nordisk shares slide after Ozempic pill fails
Novo Nordisk shares slumped over 10% after its Ozempic pill failed to slow Alzheimer's progression in major trials. Read the latest on the pharmaceutical giant's market struggles.
Keeps Secures £1.2M Funding from Investor Rush
London-based sports platform Keeps closes £1.2 million funding round as investors target sports sector. Discover how this impacts UK sports technology investment landscape.
Maximising Returns on Whisky Cask Investment
Expert advice on navigating the whisky cask investment market. Learn about long-term strategy, due diligence, and the impact of India's trade deal on Scotch demand.
Preservation Capital plots £700m investment fund
London-based investment firm Preservation Capital launches ambitious £700 million fund targeting established businesses. Discover their unique investment strategy and market focus.
UK Plans 25% NHS Drug Threshold Rise to End Standoff
UK ministers propose 25% increase in NHS drug cost-effectiveness thresholds to resolve investment row with pharmaceutical giants and boost life sciences sector.
Moelis Considers Nordic Banking Launch Amid Talent War
US investment bank Moelis & Co explores Nordic expansion as financial institutions compete fiercely for top banking talent across European markets.
Why Cask Whisky Is Your Portfolio's Liquid Safeguard
Discover how cask whisky investment offers diversification against market volatility. Learn why this tangible asset matures regardless of economic conditions from London's oldest whisky firm.
Australian banks provided $43bn to fossil fuel companies
Australia's major banks have poured $43 billion into fossil fuel companies over the past decade, with ANZ and Westpac continuing gas expansion funding. Discover the environmental impact.
Conwoman jailed in UK's biggest Bitcoin money laundering case
Zhimin Qian, known as the 'Goddess of Wealth', sentenced to 11 years for laundering £5bn in Bitcoin after orchestrating massive investment fraud. Read the full investigation details.
Former Petrofac CEO seeks £40m for Venterra wind firm
Ayman Asfari's Venterra Group aims to raise £40m amid renewable investment slowdown. Learn how political uncertainty affects offshore wind growth.
Durham's Lumiere Festival ends after 15 years
Durham's acclaimed Lumiere light festival closes after 15 years, taking £43m economic impact with it. As arts funding faces 32% cuts, we examine why cultural investment matters more than ever.
RBC Bolsters European Equities Team with Senior Hires
Royal Bank of Canada makes three strategic senior hires to expand its European equities division, enhancing research and execution capabilities across key markets.
London's Retail & Culture Sectors Seek Investment Boost
Top industry leaders call for regulatory reform and cultural investment to sustain London's global position. Discover the key insights from the Central London Alliance panel.
Investor's £30k ISA success after finfluencer warning
A Cardiff investor reveals how he built a £30,000 portfolio after learning from risky day trading. Discover the dangers of finfluencers and the power of passive investing for long-term growth.
CVC Hires KKR's James McGlade for UK Dealmaking
Private equity giant CVC Capital Partners recruits James McGlade from rival KKR to strengthen its UK financial services investments. Discover the strategic move reshaping London's dealmaking landscape.
Atletico Madrid valued at £2.2bn after Apollo deal
Atletico Madrid has been valued at £2.2bn after US firm Apollo Global Management acquired a majority stake. Discover how this private equity move reshapes European football.
DWS Tokenisation Plan & Private Markets Warning
Exclusive insights into DWS's ambitious tokenisation plans and why Allspring's CEO sounds caution on private markets. Discover how blockchain technology is reshaping investment strategies.
NHS faces generic-only drug future warns AstraZeneca
The CEO of pharmaceutical giant AstraZeneca warns that UK patients may be limited to generic medicines unless the NHS increases what it pays for innovative new treatments, raising concerns about healthcare quality and medical research funding.
Goldman Sachs hires Evercore banker for Evelyn Partners sale
In a significant recruitment coup, Goldman Sachs has hired senior Evercore banker James Rucker to spearhead the upcoming sale of Evelyn Partners' wealth management division, signalling intensified competition in London's financial advisory landscape.
Page 1 of 4